Maria Gabriella Caruso1, Maria Notarnicola. 1. Laboratory of Biochemistry, National Institute for Digestive Disease, Castellana Grotte, Bari, Italy. irccsbiochimica@libero.it
Abstract
BACKGROUND: Alterations in the mevalonate pathway may contribute to malignant cell growth. There are differences in the aetiology, clinical behaviour, pathological and genetic features in cancer of the right versus the left colon. Here, 3-hydroxy-3-methylglutatyl coenzyme A (HMG-CoA) reductase, farnesylpyrophosphate (FPP) synthase and farnesyltransferase (Ftase) activities were measured in human colorectal cancer (CRC) and normal mucosa in order to evaluate their role as potential markers of malignancy, also in relation to cancer location. PATIENTS AND METHODS: HMG-CoA reductase, FPP synthase and Ftase activities were determined in CRC and normal mucosa of 90 patients by radiochemical assay. RESULTS: The enzymatic activities were higher in cancer than in normal mucosa. The tumours located at the left side showed higher HMG-CoA reductase activity, whereas the right side tumours showed higher levels of Ftase and FPP synthase activity. CONCLUSION: The determination of mevalonate pathway enzymes in relation to CRC location may be clinically relevant in designing anticancer targeted therapies.
BACKGROUND: Alterations in the mevalonate pathway may contribute to malignant cell growth. There are differences in the aetiology, clinical behaviour, pathological and genetic features in cancer of the right versus the left colon. Here, 3-hydroxy-3-methylglutatyl coenzyme A (HMG-CoA) reductase, farnesylpyrophosphate (FPP) synthase and farnesyltransferase (Ftase) activities were measured in humancolorectal cancer (CRC) and normal mucosa in order to evaluate their role as potential markers of malignancy, also in relation to cancer location. PATIENTS AND METHODS: HMG-CoA reductase, FPP synthase and Ftase activities were determined in CRC and normal mucosa of 90 patients by radiochemical assay. RESULTS: The enzymatic activities were higher in cancer than in normal mucosa. The tumours located at the left side showed higher HMG-CoA reductase activity, whereas the right side tumours showed higher levels of Ftase and FPP synthase activity. CONCLUSION: The determination of mevalonate pathway enzymes in relation to CRC location may be clinically relevant in designing anticancer targeted therapies.
Authors: Jean-Pierre H Perchellet; Elisabeth M Perchellet; Kyle R Crow; Keith R Buszek; Neil Brown; Sampathkumar Ellappan; Ge Gao; Diheng Luo; Machiko Minatoya; Gerald H Lushington Journal: Int J Mol Med Date: 2009-11 Impact factor: 4.101
Authors: Maria Notarnicola; Maria Gabriella Caruso; Angela Tafaro; Valeria Tutino; Giusy Bianco; Mario Minoia; Antonio Francavilla Journal: World J Gastroenterol Date: 2013-12-14 Impact factor: 5.742
Authors: Maria Notarnicola; Caterina Messa; Maria G Refolo; Valeria Tutino; Angelica Miccolis; Maria G Caruso Journal: Lipids Health Dis Date: 2011-01-18 Impact factor: 3.876
Authors: J M Villadiego-Sánchez; M Ortega-Calvo; R Pino-Mejías; A Cayuela; P Iglesias-Bonilla; F García-de la Corte; J M Santos-Lozano; José Lapetra-Peralta Journal: Int J Med Sci Date: 2009-01-30 Impact factor: 3.738